Home › Breast Cancer › Massachusetts › Brockton
Breast Cancer clinical trials in Brockton, MA
5 studies for Breast Cancer are looking for participants at sites in and around Brockton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecruitingPhase 3
- Dana-Farber Brigham Cancer Center Foxborough, Foxborough · 12 mi away
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecruitingPhase 3
- Dana Farber Cancer Institute at Foxborough, Foxborough · 12 mi away
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Dana-Farber Cancer Institute at Foxborough, Foxborough · 12 mi away
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RecruitingPhase 2
- Dana-Farber Brigham Cancer Center - Foxborough, Foxborough · 12 mi away
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RecruitingPhase 2
- DFCI @ Foxborough, Foxborough · 12 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Brockton
- Multiple Sclerosis4 studies
- Alzheimer's Disease4 studies
- Prostate Cancer4 studies
- Myasthenia Gravis3 studies
- Colon Cancer3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.